StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

Purine → beta,gamma-Methylene ATP

HRID 363340
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 363340
N1C=C2C(N=CN2)=NC=1.[P:10]([O:22][CH2:23][C@H:24]1[O:28][C@@H:27]([N:29]2[C:38]3[N:37]=[CH:36][N:35]=[C:33]([NH2:34])[C:32]=3[N:31]=[CH:30]2)[C@H:26]([OH:39])[C@@H:25]1[OH:40])(OP(OP(O)(O)=O)(O)=O)(=[O:12])[OH:11].[P:41]([O:49][CH2:50][C@H:51]1[O:55][C@@H:54]([N:56]2[C:65]3[N:64]=[CH:63][N:62]=[C:60]([NH2:61])[C:59]=3[N:58]=[CH:57]2)[C@H:53]([OH:66])[C@@H:52]1[OH:67])([O:44][P:45]([OH:48])([OH:47])=[O:46])(=[O:43])[OH:42].[P:68]([O:72][CH2:73][C@H]1O[C@@H](N2C3N=CN=C(N)C=3N=C2)[C@H](O)[C@@H]1O)(O)([OH:70])=[O:69].[C@@H:91]1(N2C3N=CN=C(N)C=3N=C2)O[C@H](CO)[C@@H](O)[C@H]1O>>[CH:36]1[N:35]=[C:33]([NH2:34])[C:32]2[N:31]=[CH:30][N:29]([C@@H:27]3[O:28][C@H:24]([CH2:23][O:22][P:10]([OH:11])([CH2:73][P:41]([O:44][P:45]([OH:48])([OH:47])=[O:46])([OH:42])=[O:43])=[O:12])[C@@H:25]([OH:40])[C@H:26]3[OH:39])[C:38]=2[N:37]=1.[CH:63]1[N:62]=[C:60]([NH2:61])[C:59]2[N:58]=[CH:57][N:56]([C@@H:54]3[O:55][C@H:51]([CH2:50][O:49][P:41]([O:44][P:45]([OH:47])([CH2:91][P:68]([OH:72])([OH:70])=[O:69])=[O:46])([OH:42])=[O:43])[C@@H:52]([OH:67])[C@H:53]3[OH:66])[C:65]=2[N:64]=1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

7

Edukt 5

HCID 1044PurineHCID 59575'-AtpHCID 60225'-AdpHCID 6083Adenosine MonophosphateHCID 60961Adenosine

Produkt 2

HCID 91532beta,gamma-Methylene ATP
HCID 91557
alpha,beta-Methylene-ATP

Versuchsvorschrift

Purine compounds (ATP, adenosine 5'-diphosphate (ADP), adenosine 5'-monophosphate (AMP) and adenosine; 3-6 μmol kg-1 and capsaicin (10 μg kg-1) were given as a rapid bolus into the right atrium (5 ml test solution+5 ml physiological saline flush) or the right pulmonary artery (1 ml test solution+3 ml physiological saline flush). When given in the latter site, smaller doses were used, i.e. 0.5-3 μmol kg-1 for purine compounds and 1-5 μg kg-1 for capsaicin. α,β-Methylene ATP (α,β-mATP) and β,γ-methylene ATP (β,γ-mATP) were give as one low dose only (0.75 μmol kg-1) to avoid systemic side effects. Volume controls consisted of either 5+5 ml or 1+3 ml physiological saline. All injections were performed in the same mode by the same person. To exclude involvement of baroreceptors in the recorded neural activity, the latter was monitored before and after a bolus of nitroglycerine (1mg, I.V.; n=5). The effect of ganglionic transmission blockade on the effects of ATP and capsaicin was determined by the administration of hexamethonium (10 mg kg-1, I.V.; n=7).

Aufarbeitung

  1. custom3-6 μmol kg-1 and capsaicin (10 μg kg-1) were given as a rapid bolus into the right atrium (5 ml test solution+5 ml physiological saline flush)
  2. customthe right pulmonary artery (1 ml test solution+3 ml physiological saline flush)

Quellen und Nachweise

ORD-Eintrag
ord-a671929f76e2424f9c07f304075d24c3
Quelldatensatz
uspto-grants-1999_02
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US05874420

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion